98 related articles for article (PubMed ID: 9346826)
1. Affinity purification of a correctly folded fragment of synthetic HIV-1 mRNA using a HIV-1 Rev peptide-ligand.
Englebretsen DR; Scanlon MJ; West ML
Biomed Pept Proteins Nucleic Acids; 1996; 2(2):47-50. PubMed ID: 9346826
[TBL] [Abstract][Full Text] [Related]
2. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
3. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
4. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
Daly TJ; Doten RC; Rusche JR; Auer M
J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
[TBL] [Abstract][Full Text] [Related]
5. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes.
Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ
Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904
[TBL] [Abstract][Full Text] [Related]
6. Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.
Peterson RD; Feigon J
J Mol Biol; 1996 Dec; 264(5):863-77. PubMed ID: 9000617
[TBL] [Abstract][Full Text] [Related]
7. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
Luedtke NW; Liu Q; Tor Y
Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
[TBL] [Abstract][Full Text] [Related]
8. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
West ML; Ramsdale TE
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
[TBL] [Abstract][Full Text] [Related]
9. Retention of conformational flexibility in HIV-1 Rev-RNA complexes.
Wilkinson TA; Zhu L; Hu W; Chen Y
Biochemistry; 2004 Dec; 43(51):16153-60. PubMed ID: 15610009
[TBL] [Abstract][Full Text] [Related]
10. A simple code for protein:RNA interactions.
Ellington AD; Symensma TL; Giver L; Baskerville S
Nucleic Acids Symp Ser; 1995; (33):156-9. PubMed ID: 8643356
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 rev nuclear export signal binding peptides isolated by phage display.
Jensen A; Jensen TH; Kjems J
J Mol Biol; 1998; 283(1):245-54. PubMed ID: 9761687
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of mismatch-binding ligands as inhibitors for Rev-RRE interaction.
Nakatani K; Horie S; Goto Y; Kobori A; Hagihara S
Bioorg Med Chem; 2006 Aug; 14(15):5384-8. PubMed ID: 16603366
[TBL] [Abstract][Full Text] [Related]
13. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
Charpentier B; Stutz F; Rosbash M
J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
[TBL] [Abstract][Full Text] [Related]
14. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
15. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
[TBL] [Abstract][Full Text] [Related]
17. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region.
Wang Y; Hamasaki K; Rando RR
Biochemistry; 1997 Jan; 36(4):768-79. PubMed ID: 9020774
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of a non-nucleotide bridge into hairpin oligonucleotides capable of high-affinity binding to the Rev protein of HIV-1.
Nelson JS; Giver L; Ellington AD; Letsinger RL
Biochemistry; 1996 Apr; 35(16):5339-44. PubMed ID: 8611522
[TBL] [Abstract][Full Text] [Related]
19. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]